Hyperlipidemia and Erythrocyte Shape Change
スポンサーリンク
概要
- 論文の詳細を見る
To detect perturbations of the membrane structure and properties of mammalian erythrocyte induced by increased lipid content of the blood plasma, cellular shape changes based on conformational change of the membrane was utilized as the sensitive indicator.<BR>Erythrocytes from genetic "fatty" rat with remarkable increased VLDL level or those from nephrotic patients with increased LDL level, did not show any appreciable shape change. In contrast, elevation of the plasma level of lysolecithin or free fatty acid induced varying degrees of echinocyte-spherocyte shape change, depending on the amount of the free lipid (s) incorporated into the membrane, which was accompanied by the changes in the membrane surface area, surface charge, osmotic fragility, etc. Partial removal of these membrane lipids normally present in the erythrocyte membrane induced a stomatocyte-type shape change.<BR>From these results and from consideration of the known clinical findings on the abnormally -shaped erythrocytes in some hepatobiliary diseases and particularly in lipoprotein X cases, importance of the plasma level of the free lipids such as lysolecithin, free fatty acid and bile acids in inducing membrane perturbations on erythrocytes, and probably of some tissue cells, was emphasized. These lipids may act as "protein stabilizers" or "detergents" to give powerful effect on the membrane constituents. In contrast, the plasma lipoproteins may behave as a kind of "membrane" to fuse with the erythrocyte membrane in the presence of "detergent" lipid or to exchange the lipid constituents with it only under limited circumstances.
- Japan Society of Clinical Chemistryの論文
著者
関連論文
- マクロファージにおけるマトリックスメタロプロテアーゼ-9産生への細胞質ホスホリパーゼA_2α関与
- 肝での脂肪蓄積への group IVA phospholipase A_2 の関与
- シメチジンの用量と薬物相互作用発現の関係 : 文献調査ならびにテオフィリン体内動態の変動
- 各種ヨード造影剤のヒト血小板凝集抑制作用の比較
- 薬学に託す21世紀
- Mechanism of Antioxidant Action of Pueraria Glycoside (PG)-1 (an Isoflavonoid) and Mangiferin (a Xanthonoid)
- Antioxidant Activity of Indapamide and Its Metabolite
- 薬剤師会との連携で(活気ある支部活動)
- Relationship between Drug-and Phospholipase-Induced Shape Changes of Human Erythrocytes
- プロトポルフィリンのヒト赤血球膜に対する影響
- 諸種薬物のヒト赤血球内Kイオン流出促進効果と膜変形誘起効果との比較
- Shape-transforming Action of Myrmicacin (3-Hydroxydecanoic Acid) and Some Related Compounds on the Membrane of Intact Human Erythrocytes
- 「年会一般講演の座長のあり方」のパネルを読んで : その2
- ヒト赤血球膜に対するフェノチアジン系向精神薬の作用
- 両親媒性薬物によるヒト赤血球の変形と浸透圧抵抗性変化との関連
- Binding of Calcium and Magnesium Ions to Human Erythrocyte Membranes
- Changes in Shape and Osmotic Resistance of Human Erythrocytes resulted from Changes in the Lysolecithin Content of the Membranes
- Calcium and Magnesium Contents of Mammalian Erythrocyte Membranes
- Abnormal Distribution of Phospholipids in Aorta of the Rabbits with Experimental Atherosclerosis
- Phospholipid Distribution in Erythrocyte and Plasma of the Man, Cow, Pig and Rabbit
- 低酸素が誘導する血管平滑筋細胞遊走因子としてのトロンボスポンジン-1の作用機構(誌上シンポジウム)
- 細胞質ホスホリパーゼA_2α欠損マウスの脂肪組織および肝における脂質の蓄積低下
- 高グルコースメジウム中での培養ラットメサンギウム細胞におけるホスホリパーゼA_2活性
- 各種漢方方剤のウサギ血小板ホスホリパーゼA_2阻害効果及び高コレステロール血症ウサギの血小板凝集能亢進に対する当帰芍薬散の抑制効果
- 血液細胞の細胞膜におけるリン脂質の動態と機能.両親媒性薬物の作用機構に関連して
- まるごとの細胞で膜を研究する者の繰り言(生体膜研究の展望)
- Disturbing Effect of Cationic Amphiphilic Drugs on Phospholipid Asymmetry of the Membrane Lipid Bilayer of Human Erythrocytes
- ヒト赤血球膜に対するペニシリンの作用
- 日本薬学会教育賞受賞, 藤井達三氏の業績
- 赤血球と血小板の細胞膜における膜リン脂質の多彩な役割 (血液細胞の細胞膜の研究における最近の進歩)
- 赤血球膜の構造と機能
- 血小板の膜流動性変化とホスホリパ-ゼA2活性
- 血小板の膜流動性変化とホスホリパーゼA2活性
- 赤血球と血小板の細胞膜における膜リン脂質の多彩な役割 (血液細胞の細胞膜の研究における最近の進歩)
- Characteristics of Human Erythrocytes with Artific Ally-Increased ATP and/or 2, 3-Diphosphoglycerate Contents
- Hyperlipidemia and Erythrocyte Shape Change
- タイトル無し
- Furlher Sludies on Enzymic Determination of Plasma Sphingomyelin:The Comparison with TLC Method
- Possible Adsorption of Aldolase and Glyceraldehyde-3-Phosphate Dehydrogenase into the Erythrocyte Ghosts Prepared Under a Hypotonic Condition
- Increase in the Activity of Rhizopus C-Lipase on Human Plasma Lipoproteins by Treatment with Phospholipid